ELMIKO iCFM System

General description
The iCFM system is an advanced solution for long-term monitoring of brain activity, designed specifically for intensive care of premature infants and newborns. The system enables simultaneous recording of raw EEG signals and amplitude-integrated EEG (aEEG) trend curves, along with additional physiological parameters. This combination allows real-time visualisation of brain activity, rapid detection of neurological changes, and supports improved diagnostic and therapeutic decision-making in neonatal intensive care environments.

Applications of the ELMIKO iCFM System

• Neonatal intensive care units (NICUs)
• Neonatal pathology wards
• Neonatology wards
• Intensive care units (ICUs)
• Neurology wards
• Rehabilitation centres and facilities
• Academic and research institutes

ELMIKO iCFM System diagnostic indications
ELMIKO iCFM System is used in the diagnosis and monitoring of:

• Hypoxic-ischaemic encephalopathy – monitoring brain activity in cases of hypoxia and ischemia to optimise treatment strategies
• Seizures – detection and monitoring of seizure activity, enabling rapid intervention and assessment of the effectiveness of anticonvulsant therapy
• Therapeutic hypothermia – tracking the brain’s response to reduced body temperature used in the treatment of neurological injuries and conditions
• Sepsis – assessment of the effect of sepsis on patients’ brain functioning
• Cardiopulmonary failure – continuous monitoring of brain activity in patients with cardiopulmonary dysfunction
• Neuroinfections – tracking the impact of neurological infections, such as meningitis, on the patient’s condition
• Metabolic disorders – observing brain activity in metabolic abnormalities that may influence neurological status
• Hydrocephalus – controlling the impact of increased intracranial pressure and fluid accumulation on brain functioning
• Pharmacotherapy – assessing the brain’s response to pharmacological treatment to optimise drug dosing and therapeutic protocols

ELMIKO iCFM System functionalities

• Long-term monitoring – the module enables long-term EEG and aEEG recordings with simultaneous monitoring of physiological parameters such as SpO₂ and ECG, allowing for a comprehensive assessment of brain function in the context of the patient’s overall condition
• Customisable alerts – configurable alerts notify users when predefined thresholds for biological parameters (e.g., oxygen saturation, heart rate, or amplitude) are exceeded, enhancing patient safety during prolonged monitoring
• ECG signal display – this function enables simultaneous monitoring of heart rhythm and brain activity, thereby allowing for a more comprehensive assessment of the patient’s condition and correlation analysis between neurological and cardiological parameters.